Showing results (811-820 of 835) with videos related to
Sort By:
Pageof 84
Nature Biotechnology|November 25, 2024
Intravenous administration of blood-brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous systemChang Wang, Siyu Wang, Yonger Xue, et al.Materials Today (Kidlington, England)|October 31, 2025
Aminophosphonate-Derived Lipid Nanoparticles Enable Circular RNA Delivery for Functional Recovery after Spinal Cord InjuryHaoyuan Li, Yuebao Zhang, Yichen Zhong, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 4, 2025
Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activationXucheng Hou, Chang Wang, Yichen Zhong, et al.Nature|September 12, 2023
C. difficile intoxicates neurons and pericytes to drive neurogenic inflammationJohn Manion, Melissa A Musser, Gavin A Kuziel, et al.Physical Review Letters|November 12, 2024
Absence of Altermagnetic Spin Splitting Character in Rutile Oxide RuO_{2}Jiayu Liu, Jie Zhan, Tongrui Li, et al.Free Radical Biology & Medicine|January 31, 2026
TRIM28 aggravates myocardial infarction-induced cardiomyocyte apoptosis through regulating the stability of ATF5 via ubiquitination and SUMOylationYanying Wang, Mingyu Yang, Junting Ren, et al.Journal of Translational Medicine|September 28, 2023
Tyrosine phosphorylation of band 3 impairs the storage quality of suspended red blood cells in the Tibetan high-altitude polycythemia populationXiaodong Wu, Zhijuan Liu, Doudou Hao, et al.Advanced Materials (Deerfield Beach, Fla.)|May 3, 2025
Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal InjectionYonger Xue, Chang Wang, Haoyuan Li, et al.Journal of Virology|October 7, 2016
Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from IndiaAnmol Chandele, Jaturong Sewatanon, Sivaram Gunisetty, et al.Ebiomedicine|December 28, 2021
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trialLei Shi, Xin Yuan, Weiqi Yao, et al.Pageof 84